article at curetoday
CYDY/Leronlimab discussions. Unofficial.
Milestone
CYDY/Leronlimab discussions. Unofficial.
The energy is building. Word will spread.
CYDY/Leronlimab discussions. Unofficial.
ORR (Objective Response Rate) with Immune Checkpoint Inhibitors (ICIs)
CYDY/Leronlimab discussions. Unofficial.
some news feeds about ESMO Breast Cancer Congress 2025
CYDY/Leronlimab discussions. Unofficial.
Leronlimab increasing PD-L1 means it may unlock help for many.
CYDY/Leronlimab discussions. Unofficial.
KISS: How many are alive after 48 months?
CYDY/Leronlimab discussions. Unofficial.
Abstracts released May 8
CYDY/Leronlimab discussions. Unofficial.
Conference links May-July 2025 with leronlimab research
CYDY/Leronlimab discussions. Unofficial.
July 4th ESMO Conference in Barcelona. Leronlimab Colorectal Cancer poster
CYDY/Leronlimab discussions. Unofficial.
poster, July 4th, 2025: ESMO Gastrointestinal Cancers Congress, Madrid
CYDY/Leronlimab discussions. Unofficial.
membership here jumped up
CYDY/Leronlimab discussions. Unofficial.
discernment
CYDY/Leronlimab discussions. Unofficial.
I'd like the 4 years and more please
CYDY/Leronlimab discussions. Unofficial.
compelling
CYDY/Leronlimab discussions. Unofficial.
Leronlimab info: click here
CYDY/Leronlimab discussions. Unofficial.
MOA in oncology getting fine-tuned
CYDY/Leronlimab discussions. Unofficial.
Breast Cancer quotes from CytoDyn
CYDY/Leronlimab discussions. Unofficial.
Grit
CYDY/Leronlimab discussions. Unofficial.
some of the papers, posters, and abstracts organized by indication
CYDY/Leronlimab discussions. Unofficial.
Coming into focus now
CYDY/Leronlimab discussions. Unofficial.
LifeTracDx® liquid biopsy in a number of CytoDyn studies
CYDY/Leronlimab discussions. Unofficial.
HIV movement?
CYDY/Leronlimab discussions. Unofficial.
The next quarterly update and while I’ll read it multiple times over time.
CYDY/Leronlimab discussions. Unofficial.
The many studies in 2025 are highlighting big stuff
CYDY/Leronlimab discussions. Unofficial.
